pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2012-0-2-65-70pulmo-45Research ArticleОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯORIGINAL STUDIESАшероваИ. К.AsherovaI. K.

к. м. н., зав. отделением пульмонологии 

150003, Ярославль, пр. Ленина, 12 / 76. Тел.: (4852) 25-24-43.

irina-asherova@mail.ruМонаховаС. И.MonakhovaS. I.

зав. клинико-бактериологической лабораторией

150040, Ярославль, пр. Октября, 54. Тел.: (4852) 73-61-64.

mikrob08@yandex.ruЕршоваМ. Г.ErshovaM. G.

врач-бактериолог клинико-бактериологической лабораторией

150040, Ярославль, пр. Октября, 54. Тел.: (4852) 73-61-64.

mikrob08@yandex.ruАнгеловаС. Н.AngelovaS. N.

врач-бактериолог клинико-бактериологической лабораторией 

150040, Ярославль, пр. Октября, 54. Тел.: (4852) 73-61-64.

mikrob08@yandex.ruМедведеваЕ. Н.MedvedevaE. N.

ординатор кафедры госпитальной педиатрии

150003, Ярославль, пр. Ленина, 12 / 76.

doc-medvedeva@mail.ruМУЗ "Детская клиническая больница № 1", центр помощи больным муковисцидозомRussian FederationМУЗ "Инфекционная клиническая больница № 1"Russian FederationЯрославская государственная медицинская академияRussian Federation201228042012026570Copyright © Ашерова И.К., Монахова С.И., Ершова М.Г., Ангелова С.Н., Медведева Е.Н., 20122012Ашерова И.К., Монахова С.И., Ершова М.Г., Ангелова С.Н., Медведева Е.Н.Asherova I.K., Monakhova S.I., Ershova M.G., Angelova S.N., Medvedeva E.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/45ReferencesLiPuma J.J. Burkholderia and emerging pathogens in cystic fibrosis. Semin. Respir. Crit. Care Med. 2003; 24: 681–692.LiPuma J.J. Burkholderia and emerging pathogens in cystic fibrosis. Semin. Respir. Crit. Care Med. 2003; 24: 681–692.Hoiby N., Pressler T. Emerging pathogens in cystic fibrosis. Cyst. Fibros. Monograph. 2006; 35 (11): 66–78.Hoiby N., Pressler T. Emerging pathogens in cystic fibrosis. Cyst. Fibros. Monograph. 2006; 35 (11): 66–78.Муковисцидоз. Ранняя диагностика и лечение. / Капранов Н.И., Каширская Н.Ю., Толстова В.Д. и др. М.: ГЭОТАР-Медиа; 2008.Муковисцидоз. Ранняя диагностика и лечение. / Капранов Н.И., Каширская Н.Ю., Толстова В.Д. и др. М.: ГЭОТАР-Медиа; 2008.Early intervention and prevention of lung disease in cystic fibrosis: a European Consensus. J. Cyst. Fibros. 2004; 3 (2): 67–91.Early intervention and prevention of lung disease in cystic fibrosis: a European Consensus. J. Cyst. Fibros. 2004; 3 (2): 67–91.Smyth A. Update on treatment of pulmonary exacerbation in cystic fibrosis. Curr. Opin. Pulm. Med. 2006; 12: 440–444.Smyth A. Update on treatment of pulmonary exacerbation in cystic fibrosis. Curr. Opin. Pulm. Med. 2006; 12: 440–444.Goss C.H., Otto K., Aitken M.L. et al. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2002; 166: 356–361.Goss C.H., Otto K., Aitken M.L. et al. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 2002; 166: 356–361.Goss C.H., Mayer*Hamblett N., Aitken M.L. et al. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax 2004; 59: 955–959.Goss C.H., Mayer*Hamblett N., Aitken M.L. et al. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax 2004; 59: 955–959.Cystic fibrosis in children and adults. The Leeds method of management.: St. James's University Hospital, UK; 2008. November 7.Cystic fibrosis in children and adults. The Leeds method of management.: St. James's University Hospital, UK; 2008. November 7.de Baets F., Schelstraete P., van Daele S. et al. Achromobacter хylosoxidans in cystic fibrosis: prevalence and clinical relevance. J. Cyst. Fibros. 2007; 6 (1): 75–78.de Baets F., Schelstraete P., van Daele S. et al. Achromobacter хylosoxidans in cystic fibrosis: prevalence and clinical relevance. J. Cyst. Fibros. 2007; 6 (1): 75–78.Brown B. et al. In: The 22th Annual North American Cystic Fibrosis Foundation Conference (NACFC). Orlando, Florida; 2008; abs. 359.Brown B. et al. In: The 22th Annual North American Cystic Fibrosis Foundation Conference (NACFC). Orlando, Florida; 2008; abs. 359.Hansen C.R., Pressler T., Nielsen K.G. et al. Inflammation in Achromobacter хylosoxidans infected cystic fibrosis patients. J. Cyst. Fibros. 2010; 9 (1): 51–58.Hansen C.R., Pressler T., Nielsen K.G. et al. Inflammation in Achromobacter хylosoxidans infected cystic fibrosis patients. J. Cyst. Fibros. 2010; 9 (1): 51–58.Van Daele S., Verhelst R., Claeys G. et al. Shared genotypes of Achromobacter хylosoxidans strains isolated from patients at cystic fibrosis rehabilitation center. J. Clin. Microbiol. 2005; 43: 2998–3002.Van Daele S., Verhelst R., Claeys G. et al. Shared genotypes of Achromobacter хylosoxidans strains isolated from patients at cystic fibrosis rehabilitation center. J. Clin. Microbiol. 2005; 43: 2998–3002.Balfour*Lynn I.M., Elborn J.S. Respiratory disease: infection. In: Hodson M., Geddes D., Bush A., eds. Cystic fibrosis, 3rd ed. London; 2007. 137–159.Balfour*Lynn I.M., Elborn J.S. Respiratory disease: infection. In: Hodson M., Geddes D., Bush A., eds. Cystic fibrosis, 3rd ed. London; 2007. 137–159.Lee T.W., Brownlee K.G., Conway S.P. et al. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J. Cyst. Fibros. 2003; 2: 29–34.Lee T.W., Brownlee K.G., Conway S.P. et al. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J. Cyst. Fibros. 2003; 2: 29–34.

The authors declare that there are no conflicts of interest present.